U.S. Markets close in 1 hr 9 mins

Sarepta Therapeutics, Inc. (SRPT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
80.23-1.91 (-2.33%)
As of 2:51PM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.55
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3181.83
52 Week Low 367.68
50-Day Moving Average 375.83
200-Day Moving Average 398.47

Share Statistics

Avg Vol (3 month) 31.19M
Avg Vol (10 day) 31.45M
Shares Outstanding 579.75M
Implied Shares Outstanding 6N/A
Float 75.64M
% Held by Insiders 14.80%
% Held by Institutions 189.71%
Shares Short (Apr 14, 2021) 47.27M
Short Ratio (Apr 14, 2021) 46.99
Short % of Float (Apr 14, 2021) 410.69%
Short % of Shares Outstanding (Apr 14, 2021) 49.11%
Shares Short (prior month Mar 14, 2021) 46.82M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:6
Last Split Date 3Jul 11, 2012

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020


Profit Margin -102.60%
Operating Margin (ttm)-104.44%

Management Effectiveness

Return on Assets (ttm)-14.67%
Return on Equity (ttm)-70.14%

Income Statement

Revenue (ttm)540.1M
Revenue Per Share (ttm)6.93
Quarterly Revenue Growth (yoy)45.00%
Gross Profit (ttm)-245.53M
EBITDA -537.15M
Net Income Avi to Common (ttm)-554.13M
Diluted EPS (ttm)-7.11
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.94B
Total Cash Per Share (mrq)24.41
Total Debt (mrq)1.09B
Total Debt/Equity (mrq)143.59
Current Ratio (mrq)5.97
Book Value Per Share (mrq)9.60

Cash Flow Statement

Operating Cash Flow (ttm)107.47M
Levered Free Cash Flow (ttm)-301.29M